Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATURN: Erlotinib Maintenance in Advanced NSCLC
NCT00556712Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2006
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Jan 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00556712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556712.